Sie suchten nach: anġjoġenesi (Maltesisch - Englisch)

qed tieħu inibituri tal-anġjoġenesi (bħal bevacizumab, jew thalidomide),
you are taking angiogenesis inhibitors (such as bevacizumab, or thalidomide),

għaldaqstant, intwera li g- csf jikkaġuna funzjonijiet taċ- ċelluli endoteljali marbuta mal- anġjoġenesi.
accordingly, g-csf has been shown to induce endothelial cell functions related to angiogenesis.

33 għajxien taċ- ċellula, l- anġjoġenesi, interazzjonijiet bejn iċ- ċelluli u l- metastażi.
in myeloma, bortezomib affects the ability of myeloma cells to interact with the bone marrow microenvironment.

pomalidomide jinibixxi wkoll l- anġjoġenesi billi jimblokka l-migrazzjoni u l-adeżjoni ta’ ċelluli endoteljali.
pomalidomide also inhibits angiogenesis by blocking the migration and adhesion of endothelial cells.

qed tieħu inibituri tal-anġjoġenesi (bħal bevacizumab, jew thalidomide) li jintużaw għall-kura tal-kanċer,
you are taking angiogenesis inhibitors (such as bevacizumab, or thalidomide) which are used in the treatment of cancer,

terapiji mogħtija fl-istess waqt: kortikosterojdi, kimoterapija, inibituri tal-anġjoġenesi, radjuterapija għar-ras u l-għonq
concomitant therapies: corticosteroids, chemotherapy, angiogenesis inhibitors, radiotherapy to head and neck

iggs huma magħrufa li jgħaddu mil-plaċenta, u avastin huwa mistenni li jimpedixxi anġjoġenesi fil-fetu, u għalhekk hu maħsub li jikkawża difetti serji tat-twelid meta jingħata waqt it-tqala.
iggs are known to cross the placenta, and avastin is anticipated to inhibit angiogenesis in the foetus, and thus is suspected to cause serious birth defects when administered during pregnancy.